SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 730,979.74 |
Enterprise Value ($M) | 758,922.14 |
Book Value ($M) | 14,320.70 |
Book Value / Share | 15.90 |
Price / Book | 51.04 |
NCAV ($M) | -29,871.10 |
NCAV / Share | -33.17 |
Price / NCAV | -24.47 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.18 |
Return on Assets (ROA) | 0.14 |
Return on Equity (ROE) | 0.74 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.97 |
Current Ratio | 1.27 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 31,415.10 |
Assets | 75,606.90 |
Liabilities | 61,286.20 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Pnc Financial Services Group, Inc. | 5.39 | -0.64 | |
13G/A | Vanguard Group Inc | 7.54 | -2.49 | |
13G/A | BlackRock Inc. | 6.80 | -1.67 | |
13G/A | Lilly Endowment Inc | 10.51 | -3.09 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
511,057 | 3,351,360 | 15.25 | |
329,037 | 2,363,149 | 13.92 | |
564,916 | 2,984,973 | 18.93 | |
377,990 | 2,256,796 | 16.75 | |
(click for more detail) |
Similar Companies | |
---|---|
ELAN – Elanco Animal Health Incorporated | HYAC – Haymaker Acquisition Corp. 4 |
JNJ – Johnson & Johnson | MRK – Merck & Co., Inc. |
NUVB – Nuvation Bio Inc. |